Our results showed that AR-V7 could upregulate the expression of these pro-oncogenic genes, and directly or indirectly potentiate the c-MYC-related oncogenic processes, resulting in exacerbation of the c-MYC-driven HCC. This evidence concerns the gene AR and hepatocellular carcinoma.